Hata Yujiro S — SEC Form 4 filings
SEC reporting owner CIK 1649119. 11 Form 4 filings on record with FilingPulse; latest filed 2026-03-13.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-17 to 2026-03-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 4 filings — 350,000 shares, $14,931,983 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 75,815 shares @ $45.15 ($3,422,835) in IDEAYA Biosciences, Inc., filed 2024-02-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | President and CEO, Director | 8 | — | 13 legs · 350,000 sh · $14,931,983 | 21 |
| ENANTA PHARMACEUTICALS INC (ENTA) | Director | 3 | — | — | 3 |
Form 4 filings — Hata Yujiro S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-13 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 15,700 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Option exercise (M): 12,808 @ $19.52 · Option exercise (M): 12,808 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Option exercise (M): 56,711 @ $4.31 · Sale (S): 54,408 @ $41.60 · Sale (S): 2,303 @ $41.84 · Option exercise (M): 83,856 @ $4.31 · Sale (S): 53,592 @ $42.57 · Sale (S): 29,761 @ $43.48 · +7 more | EDGAR |
| 2024-03-08 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 15,700 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 480,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Option exercise (M): 75,815 @ $4.31 · Sale (S): 75,815 @ $45.15 · Option exercise (M): 23,557 @ $4.31 · Sale (S): 23,557 @ $45.54 · Option exercise (M): 75,815 (derivative) @ $0 · Option exercise (M): 23,557 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Option exercise (M): 628 @ $4.31 · Sale (S): 624 @ $45 · Sale (S): 4 @ $45.01 · Option exercise (M): 628 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Option exercise (M): 12,261 @ $4.31 · Sale (S): 12,261 @ $40.04 · Option exercise (M): 62,739 @ $4.31 · Sale (S): 62,739 @ $40.17 · Option exercise (M): 12,261 (derivative) @ $0 · Option exercise (M): 62,739 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1649119 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →